| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |